Breaking News

Rentschler Biopharma Launches New LVV Mfg. Toolbox for ATMPs

Offering includes process development and cGMP manufacturing services at Stevenage, UK site.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Rentschler Biopharma SE, a global CDMO for biopharmaceuticals, including advanced therapy medicinal products (ATMPs), launched an expanded service offering at its dedicated advanced therapies site in Stevenage, UK. This enhancement introduces a new lentiviral vector manufacturing (LVV) toolbox, complementing the company’s existing adeno-associated viral (AAV) vector services. The expanded capabilities offer a comprehensive suite of services in the advanced therapy landscape.   LVVs are becomin...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters